Minireview: Computer simulations of blood pressure regulation by the renin-angiotensin system

被引:45
作者
Takahashi, N [1 ]
Hagaman, JR [1 ]
Kim, HS [1 ]
Smithies, O [1 ]
机构
[1] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA
关键词
D O I
10.1210/en.2002-221045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Gene targeting experiments in mice have been used by us and others to test whether quantitative changes in gene expression in the renin-angiotensin system affect blood pressure. Surprisingly, these studies showed that blood pressure does not change with mild quantitative changes in the expression of the angiotensin converting enzyme (ACE). Yet, ACE inhibitors are widely used for the treatment of hypertension. This apparent paradox motivated us to develop a simple computer simulation, which qualitatively reconciled the paradox. We have now improved the simulation by including blood pressure as an explicit variable and by adding the kallikrein-kinin system and feedback control of plasma renin via plasma angiotensin II levels. The new simulation now matches quantitative aspects of the experimental data and suggests that a decrease in bradykinin plays an important role in the increased risk of diabetic nephropathy associated with genetically determined higher levels of ACE activity. This emphasizes that the value of these types of simulation lies in the thoughts that they provoke rat-her than in their ability to replicate experimental data.
引用
收藏
页码:2184 / 2190
页数:7
相关论文
共 49 条
[1]   Regulation of renin: new evidence from cultured cells and genetically modified mice [J].
Bader, M ;
Ganten, D .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2000, 78 (03) :130-139
[2]   PROTEINURIA - VALUE AS PREDICTOR OF CARDIOVASCULAR MORTALITY IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
BORCHJOHNSEN, K ;
KREINER, S .
BMJ-BRITISH MEDICAL JOURNAL, 1987, 294 (6588) :1651-1654
[3]   Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].
Brenner, BM ;
Cooper, ME ;
de Zeeuw, D ;
Keane, WF ;
Mitch, WE ;
Parving, HH ;
Remuzzi, G ;
Snapinn, SM ;
Zhang, ZX ;
Shahinfar, S .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869
[4]  
Briggs Josephine P., 1995, P1359
[5]   Recent insight into therapy of congestive heart failure: Focus on ACE inhibition and angiotensin-II antagonism [J].
Brunner-la Rocca, HP ;
Vaddadi, G ;
Esler, MD .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (05) :1163-1173
[6]   EFFECTS OF CONVERTING-ENZYME INHIBITORS ON ANGIOTENSIN AND BRADYKININ PEPTIDES [J].
CAMPBELL, DJ ;
KLADIS, A ;
DUNCAN, AM .
HYPERTENSION, 1994, 23 (04) :439-449
[7]  
Caramori M.L., 2001, PRIMER KIDNEY DIS, P212
[8]  
Carretero Oscar A., 1995, P983
[9]   Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data [J].
Chaturvedi, N .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) :370-379
[10]   Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice [J].
Davisson, RL ;
Ding, YM ;
Stec, DE ;
Catterall, JF ;
Sigmund, CD .
PHYSIOLOGICAL GENOMICS, 1999, 1 (01) :3-9